China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft capsule, which is made from frog oil, soybean isoflavone, procyanidine, and vitamin E for freckle removal and skin moisture supplements under the QunLe brand; and propolis and black ant capsule that is made from propolis, black ant, acanthopanax, and astragalus root under the Kindlink brand. In addition, the company offers health products for acne removal, relieving eyestrain, enhancing bone density, enhancing memory, enhancing nutritional anemia and chloasma, relaxing bowels and promoting the discharge of lead, enhancing immunity and relieving physical fatigue, and dispelling chloasma, as well as iron and multivitamin, and mineral supplements. Further, it manufactures and sells various types of medical drugs, such as enema glycerini, umguentumacidi borici camphoratum, ge hong beriberi water, pelvic inflammation suppository, injury and paralysis tincture, indometacin and furazolidone suppositories, injury and rheumatism relieving paste, refining goupi cream, muskiness pain relieving paste, muskiness bone strengthener paste, matrine suppositories, ethacriding lactate solution, iodine tincture, mercurochrome solution, hydrogen peroxide solution, halcinonide cream, compound fluocinonide tincture, and policresulen vaginal suppository. The company primarily sells its products through sales personnel and sales agents. China Health Industries Holdings, Inc. was founded in 1996 and is based in Harbin City, the People's Republic of China.
Stock data | 2023 | Change |
---|---|---|
Price | $0.28 | N/A |
Market Cap | $18.35M | N/A |
Shares Outstanding | 65.54M | 0.00% |
Employees | 32.00 | N/A |
Shareholder Equity | 39.11M | -8.63% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -45.16 | N/A |
P/S Ratio | 164.47 | N/A |
P/B Ratio | 0.47 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0105 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $111.58K | N/A |
Earnings | -$408.77K | N/A |
EPS | -0.0062 | N/A |
Earnings Yield | -0.0221 | N/A |
Gross Margin | 0.002 | N/A |
Operating Margin | -16.51 | N/A |
Net income margin | -3.66 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $45.08M | N/A |
Cash on Hand | $47.25K | N/A |
Debt to Equity | 0.1527 | -17.72% |
Current Ratio | $6.86 | 19.52% |